B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors

Xingli Zhao; Zhuoran Zhang; Dayson Moreira; Yu-Lin Su; Haejung Won; Tomasz Adamus; Zhenyuan Dong; Yong Liang; Hongwei H. Yin; Piotr Swiderski; Raju K. Pillai; Larry Kwak; Stephen Forman; Marcin Kortylewski

doi:https://doi.org/10.1016/j.ymthe.2018.01.007

B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors

Identifier:nobleid.org/w1/20260418/4FE8B20C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/4FE8B20C.svg?ark=w1%2F20260418%2F4FE8B20C)](https://nobleid.org/work/w1/20260418/4FE8B20C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors

Identifier:nobleid.org/w1/20260418/4FE8B20C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/4FE8B20C.svg?ark=w1%2F20260418%2F4FE8B20C)](https://nobleid.org/work/w1/20260418/4FE8B20C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work